Richard L White

Summary

Affiliation: Carolinas Medical Center
Country: USA

Publications

  1. pmc Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture
    Leonardo Rossi
    Department of Human Morphology and Applied Biology, University of Pisa, 56126 Pisa, Italy
    J Transl Med 4:5. 2006
  2. doi request reprint Cancer immunotherapy
    Richard L White
    Division of Surgical Oncology, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA
    Surg Oncol Clin N Am 20:531-54, ix. 2011
  3. pmc Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database
    Richard L White
    Department of General Surgery, Division of Surgical Oncology, Blumenthal Cancer Center, Carolinas Medical Center, Charlotte, NC, USA
    Ann Surg Oncol 18:3593-600. 2011
  4. doi request reprint Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma
    Dale Han
    Dale Han, Jonathan S Zager, Sanjana Iyengar, Mia Djulbegovic, Jaimie L Weber, Suroosh S Marzban, Vernon K Sondak, and Jane L Messina, Moffitt Cancer Center, Tampa Eli Avisar, University of Miami, Miami, FL Yu Shyr, Heidi Chen, and Lynne D Berry, Vanderbilt University School of Medicine, Nashville, TN John T Vetto, Oregon Health and Science University, Portland, OR Richard L White, Carolinas Medical Center, Charlotte, NC Barbara Pockaj, Mayo Clinic, Scottsdale Robert Krouse, Southern Arizona Veterans Administration Health Care System, Tucson, AZ Nicola Mozzillo, Istituto Nazionale dei Tumori Fondazione Pascale, Naples, Italy Kim James Charney, St Joseph Hospital, Orange and Mohammed Kashani Sabet and Stanley P Leong, California Pacific Medical Center and Research Institute, San Francisco, CA
    J Clin Oncol 31:4387-93. 2013
  5. doi request reprint Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer
    Virginia H Stell
    Carolinas Medical Center, Blumenthal Cancer Center, Department of Surgery, Division of Surgical Oncology, Charlotte, NC 28204, USA
    Breast J 17:71-4. 2011
  6. doi request reprint Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome
    David M Foureau
    Department of General Surgery, Carolinas HealthCare System, Charlotte, NC, 28203, USA
    Cancer Immunol Immunother 63:1329-40. 2014
  7. ncbi request reprint Method of biopsy and incidence of positive margins in primary melanoma
    Virginia H Stell
    Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA
    Ann Surg Oncol 14:893-8. 2007
  8. doi request reprint Effect of intraoperative radiocolloid injection on sentinel lymph node biopsy in patients with breast cancer
    Virginia H Stell
    Department of Surgery, Division of Surgical Oncology, Carolinas Medical Center, Blumenthal Cancer Center, Charlotte, NC, USA
    Ann Surg Oncol 16:2300-4. 2009
  9. doi request reprint Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature
    Teresa Flippo-Morton
    Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, North Carolina
    Breast J 22:35-44. 2016
  10. ncbi request reprint High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies?
    Asim Amin
    Division of Immunotherapy, Levine Cancer Institute, Carolinas Medical Center, Charlotte, North Carolina 28204, USA
    Oncology (Williston Park) 27:680-91. 2013

Collaborators

Detail Information

Publications15

  1. pmc Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture
    Leonardo Rossi
    Department of Human Morphology and Applied Biology, University of Pisa, 56126 Pisa, Italy
    J Transl Med 4:5. 2006
    ..By using SELDI immunoaffinity capture technology we describe two mature isoforms both present in serum before and after high-dose IL-2 immunotherapy...
  2. doi request reprint Cancer immunotherapy
    Richard L White
    Division of Surgical Oncology, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA
    Surg Oncol Clin N Am 20:531-54, ix. 2011
    ....
  3. pmc Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database
    Richard L White
    Department of General Surgery, Division of Surgical Oncology, Blumenthal Cancer Center, Carolinas Medical Center, Charlotte, NC, USA
    Ann Surg Oncol 18:3593-600. 2011
    ..This study investigated the significance of factors for predicting regional nodal disease in cutaneous melanoma using a large multicenter database...
  4. doi request reprint Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma
    Dale Han
    Dale Han, Jonathan S Zager, Sanjana Iyengar, Mia Djulbegovic, Jaimie L Weber, Suroosh S Marzban, Vernon K Sondak, and Jane L Messina, Moffitt Cancer Center, Tampa Eli Avisar, University of Miami, Miami, FL Yu Shyr, Heidi Chen, and Lynne D Berry, Vanderbilt University School of Medicine, Nashville, TN John T Vetto, Oregon Health and Science University, Portland, OR Richard L White, Carolinas Medical Center, Charlotte, NC Barbara Pockaj, Mayo Clinic, Scottsdale Robert Krouse, Southern Arizona Veterans Administration Health Care System, Tucson, AZ Nicola Mozzillo, Istituto Nazionale dei Tumori Fondazione Pascale, Naples, Italy Kim James Charney, St Joseph Hospital, Orange and Mohammed Kashani Sabet and Stanley P Leong, California Pacific Medical Center and Research Institute, San Francisco, CA
    J Clin Oncol 31:4387-93. 2013
    ..Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are continually evolving. We present a large multi-institutional study to determine factors predictive of sentinel lymph node (SLN) metastasis in thin melanoma...
  5. doi request reprint Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer
    Virginia H Stell
    Carolinas Medical Center, Blumenthal Cancer Center, Department of Surgery, Division of Surgical Oncology, Charlotte, NC 28204, USA
    Breast J 17:71-4. 2011
    ..0; NON=16.4; p=0.047). Sentinel node biopsy performed after neo-adjuvant chemotherapy appears to be an oncologically sound procedure and may save some patients the morbidity of a complete lymph node dissection...
  6. doi request reprint Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome
    David M Foureau
    Department of General Surgery, Carolinas HealthCare System, Charlotte, NC, 28203, USA
    Cancer Immunol Immunother 63:1329-40. 2014
    ....
  7. ncbi request reprint Method of biopsy and incidence of positive margins in primary melanoma
    Virginia H Stell
    Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA
    Ann Surg Oncol 14:893-8. 2007
    ..Initial biopsies with a positive deep margin suggest inadequate sampling, potentially limiting accurate staging and affecting treatment decisions...
  8. doi request reprint Effect of intraoperative radiocolloid injection on sentinel lymph node biopsy in patients with breast cancer
    Virginia H Stell
    Department of Surgery, Division of Surgical Oncology, Carolinas Medical Center, Blumenthal Cancer Center, Charlotte, NC, USA
    Ann Surg Oncol 16:2300-4. 2009
    ..Injection after anesthesia eliminates this discomfort but allows less time for radiocolloid migration. Our goal was to validate the efficacy of intraoperative injection...
  9. doi request reprint Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature
    Teresa Flippo-Morton
    Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, North Carolina
    Breast J 22:35-44. 2016
    ..Consistently high rates of RRSO uptake and short intervals from time-of-testing to RRSO demonstrate that RRSO is still more acceptable to this population than RRM. ..
  10. ncbi request reprint High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies?
    Asim Amin
    Division of Immunotherapy, Levine Cancer Institute, Carolinas Medical Center, Charlotte, North Carolina 28204, USA
    Oncology (Williston Park) 27:680-91. 2013
    ....
  11. doi request reprint Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model
    David M Foureau
    Department of General Surgery, Carolinas Medical Center, 1000 Blythe Boulevard, Charlotte, NC 28203, USA
    Cancer Immunol Immunother 60:1347-56. 2011
    ..Additionally, these data may provide insight to predict response in patients with melanoma undergoing rhIL-2 treatment...
  12. doi request reprint Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model
    Shoko E Abe
    Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina
    J Surg Oncol 112:443-8. 2015
    ..We hypothesize that not routinely re-excising close margins results in decreased costs without compromising care...
  13. doi request reprint Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies
    Benjamin C Calhoun
    Carolinas Pathology Group, Levine Cancer Institute, Charlotte, NC, USA
    Mod Pathol 28:670-6. 2015
    ..Excision may not be necessary for patients without remaining calcifications following core biopsy. ..
  14. ncbi request reprint A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer
    Melissa M Guerra-Wallace
    Blumenthal Cancer Center, Charlotte, NC, USA
    Am J Surg 188:395-8. 2004
    ..This study evaluated the incidence of cancer (in situ/invasive) in core biopsies and in subsequent surgical biopsy specimens after an initial core biopsy identifying CAPSS...
  15. ncbi request reprint Update on the NSABP and ACOSOG breast cancer sentinel node trials
    Richard L White
    Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina 28232 2861, USA
    Am Surg 70:420-4. 2004
    ..Overall survival, disease-free survival, local regional control, and morbidity serve as end points. This trial is currently enrolling patients...